Loading...
OTCM
CYDX
Market cap2mUSD
Jul 09, Last price  
0.42USD
1D
0.00%
1Q
-31.15%
Jan 2017
6,361.54%
IPO
5,150.00%
Name

Cyduct Diagnostics Inc

Chart & Performance

D1W1MN
OTCM:CYDX chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
12.23%
Rev. gr., 5y
-18.32%
Revenues
71k
-16.33%
266,212262,594232,212184,325194,435160,82694,054119,33984,48470,687
Net income
-414k
L-1.06%
-3,647,568-1,477,245-617,4911,915,600559,052-372,034-420,492-472,741-418,033-413,614
CFO
-72k
L-58.83%
0-58,6080-11,541-12,199-57,948-127,733-266,854-174,833-71,980

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
IPO date
Jun 21, 2001
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT